Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc ONCY


Primary Symbol: T.ONC

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Post by Noteableon Nov 16, 2022 5:17pm
1329 Views
Post# 35104875

Tactics used x Hedge Fund & MM to acquire shareholder stock

Tactics used x Hedge Fund & MM to acquire shareholder stockThese trading bad actors will use well worn manipulative tactics to obtain control of as many cheap stock shares as they possibly can when they see the winfall profits just ahead. They will use tactics like the 'anchoring effect' as used by Hcallahan44 and Buckhenry or accusatory and abusive language like that again used by Buckhenry to run away from the truth.  This practice is to try to confuse, distort and distract away from the solid facts about a stock and replace it with "alternative facts" which was seen used in the last Presidential election in an attempt try to deny the public from the truth. These old manipulative practices are routinely used by paid hedge fund employees trying to manipulate and control the dialogue as they try to acquire as many shareholder shares as possible, at the lowest price possible, just prior to an anticipated event usually followed by M&A or other binary announcement.



<< Previous
Bullboard Posts
Next >>